TNFRSF17
Tumor necrosis factor receptor superfamily member 17
Also known as: BCM, BCMA, CD269, TNFRSF13A, TNR17_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q02223
- Gene
- TNFRSF17
- Ensembl
- ENSG00000048462
- Chromosome
- 16
- Canonical length
- 184 aa
- Protein class
- Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Golgi apparatus,Mitotic spindle
OverviewNCBI Gene
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in mature B lymphocytes, and may be important for B cell development and autoimmune response. This receptor has been shown to specifically bind to the tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B/TALL-1/BAFF), and to lead to NF-kappaB and MAPK8/JNK activation. This receptor also binds to various TRAF family members, and thus may transduce signals for cell survival and proliferation. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
184 residues, UniProt reviewed canonical sequence.
>Q02223|TNFRSF17
1 MLQMAGQCSQ NEYFDSLLHA CIPCQLRCSS NTPPLTCQRY CNASVTNSVK GTNAILWTCL
61 GLSLIISLAV FVLMFLLRKI NSEPLKDEFK NTGSGLLGMA NIDLEKSRTG DEIILPRGLE
121 YTVEECTCED CIKSKPKVDS DHCFPLPAME EGATILVTTK TNDYCKSLPA ALSATEIEKS
181 ISARLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNFRSF17 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 45 nTPM
- lymph node: 30 nTPM
- duodenum: 27 nTPM
- colon: 27 nTPM
- stomach: 23 nTPM
- spleen: 21 nTPM
Single-cell type
- plasma cells: 567 nCPM
- foveolar cells: 28 nCPM
- gastric chief cells: 20 nCPM
- pdcs: 15 nCPM
- b-cells: 15 nCPM
- late primary spermatocytes: 12 nCPM
Immune cell
- memory B-cell: 125 nTPM
- naive B-cell: 109 nTPM
- plasmacytoid DC: 104 nTPM
- total PBMC: 13 nTPM
- neutrophil: 1.7 nTPM
- basophil: 1.3 nTPM
Brain region
- white matter: 3.8 nTPM
- cerebellum: 3.7 nTPM
- basal ganglia: 3.6 nTPM
- medulla oblongata: 3.6 nTPM
- hippocampal formation: 3.3 nTPM
- thalamus: 3.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TNFRSF17.
Disease | ImmuneIEDB
Conditions an epitope on TNFRSF17 was assayed in.
- multiple myeloma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.88
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.24
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- lymphocyte homeostasis
- signal transduction
- tumor necrosis factor-mediated signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Tumor necrosis factor receptor 13C/17
- BCMA, TALL-1 binding
- Tumour necrosis factor receptor 17
- BCMA, TALL-1 binding
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNFRSF17 as an antibody target. Whether an autoantibody or antibody against TNFRSF17 could matter depends on whether native TNFRSF17 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNFRSF17 is annotated at the cell surface, where native TNFRSF17 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- This receptor is preferentially expressed in mature B lymphocytes, and may be important for B cell development and autoimmune response.
Loading the interactive Seroatlas protein explorer...